Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 2/2017

01-02-2017 | Cardiac Nuclear Imaging (A Cuocolo and M Petretta, Section Editors)

Nuclear Cardiology for the Prediction of Response to Cardiac Resynchronization Therapy

Authors: Chetan D. Patel, Anirban Mukherjee

Published in: Current Cardiovascular Imaging Reports | Issue 2/2017

Login to get access

Abstract

Purpose of Review

About one-third patients selected for cardiac resynchronization therapy (CRT) based on conventional criteria do not show favourable response. Assessment of cardiac mechanical dyssynchrony by nuclear medicine techniques has generated considerable interest in recent years as an additional tool to improve the outcome of patients submitted to CRT.

Recent Findings

Several studies in recent years have shown the utility of equilibrium radionuclide angiography (ERNA) and gated myocardial perfusion SPECT (GMPS) in predicting response to CRT. Both ERNA and GMPS can assess cardiac mechanical dyssynchrony quantitatively; GMPS in addition can also provide information on the presence of scar and site of the latest mechanical activation, thereby determining the optimal site of lead placement. Limited studies have also shown the utility of gated blood-pool SPECT, gated myocardial PET and cardiac autonomic imaging in predicting response to CRT.

Summary

Nuclear medicine techniques are useful for prediction of response to CRT.
Literature
1.
Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.CrossRefPubMed
2.
• Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Drazner MH, et al. 2013ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147–239. Recent clinical indications for CRT.CrossRefPubMed
3.
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–53.CrossRefPubMed
4.
Fox DJ, Fitzpatrick AP, Davidson NC. Optimization of cardiac resynchronization therapy: addressing the problem of ‘nonresponders’. Heart. 2005;91:1000–2.CrossRefPubMedPubMedCentral
5.
Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol. 2004;44:1–9.CrossRefPubMed
6.
• Singh H, Singhal A, Sharma P, Patel CD, Seth S, Malhotra A. Quantitative assessment of cardiac mechanical synchrony using equilibrium radionuclide angiography. J Nucl Cardiol. 2013;20:415–25. First major paper to propose normal values of cardiac mechanical dyssynchrony using ERNA.CrossRefPubMed
7.
Bader H, Garrigue S, Lafitte S, Reuter S, Jaïs P, Haïssaguerre M, et al. Intra-left ventricular electromechanical asynchrony: a new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol. 2004;43:248–56.CrossRefPubMed
8.
Cho GY, Song JK, Park WJ, Han SW, Choi SH, Doo YC, et al. Mechanical dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS duration. J Am Coll Cardiol. 2005;46:2237–43.CrossRefPubMed
9.
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–16.CrossRefPubMed
10.
Frais M, Botvinick E, Shosa D, O’Connell W, Pacheco Alvarez J, Dae M, et al. Phase image characterization of localized and generalized left ventricular contraction abnormalities. J Am Coll Cardiol. 1984;4:987–98.CrossRefPubMed
11.
Strauss HW, Zaret BL, Hurley PJ Natarajan TK, Pitt B. A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Am J Cardiol. 1971;28:575–80.CrossRefPubMed
12.
Botvinick EH, Dunn R, Frais M, O’Connell W, Shosa D, Herfkens R, et al. The phase image: its relationship to patterns of contraction and conduction. Circulation. 1982;65:551–60.CrossRefPubMed
13.
Dauphin R, Nonin E, Bontemps L, Vincent M, Pinel A, Bonijoly S, et al. Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients—a prospective long-term study. Circ Cardiovasc Imaging. 2011;4:114–21.CrossRefPubMed
14.
Mukherjee A, Patel CD, Naik N, Sharma G, Roy A, et al. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with non-ischaemic dilated cardiomyopathy using equilibrium radionuclide angiography. Europace. 2016;18:851–7.CrossRefPubMed
15.
Burri H, Domenichini G, Sunthorn H, Fleury E, Stettler C, Foulkes I, et al. Right ventricular systolic function and cardiac resynchronization therapy. Europace. 2012;12:389–94.CrossRef
16.
Mukherjee A, Patel CD, Roy A, Sharma G, Naik N. Interplay between right ventricular mechanical dyssynchrony and cardiac resynchronization therapy in patients with nonischemic dilated cardiomyopathy. Nucl Med Commun. 2016;37:1016–23.CrossRefPubMed
17.
Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG gated myocardial perfusion SPECT imaging: development of a SPECT myocardial perfusion imaging diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol. 2005;12:687–95.CrossRefPubMed
18.
Trimble MA, Velazquez EJ, Adams GL, Honeycutt EF, Pagnanelli RA, Barnhart HX, et al. Repeatability and reproducibility of phase analysis of gated SPECT myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl Med Commun. 2008;29:374–81.CrossRefPubMedPubMedCentral
19.
Lin X, Xu H, Zhao X, Folks RD, Garcia EV, Soman P, et al. Repeatability of left ventricular dyssynchrony and function parameters in serial gated myocardial perfusion SPECT studies. J Nucl Cardiol. 2010;17:811–6.CrossRefPubMedPubMedCentral
20.
Mukherjee A, Singh H, Patel C, Sharma G, Roy A, Naik N, et al. Normal values of cardiac mechanical synchrony parameters using gated myocardial perfusion single-photon emission computed tomography: impact of population and study protocol. Indian J Nucl Med. 2016;31:255–9.CrossRefPubMedPubMedCentral
21.
Romero-Farina G, Aguadé-Bruix S, Candell-Riera J, Pizzi MN, García-Dorado D. Cut-off values of myocardial perfusion gated-SPECT phase analysis parameters of normal subjects, and conduction and mechanical cardiac diseases. J Nucl Cardiol. 2015;22:1247–58.CrossRefPubMed
22.
AlJaroudi W, Jaber WA, Grimm RA, Marwick T, Cerqueira MD. Alternative methods for the assessment of mechanical dyssynchrony using phase analysis of gated single photon emission computed tomography myocardial perfusion imaging. Int J Cardiovasc Imaging. 2012;28:1385–94.CrossRefPubMed
23.
Henneman MM, Chen J, Dibbets–Schneider P, Stokkel MP, Bleeker GB, Ypenburg C, et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med. 2007;48:1104–11.CrossRefPubMed
24.
Mukherjee A, Patel CD, Naik N, Sharma G, Roy A, et al. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with nonischaemic dilated cardiomyopathy using gated myocardial perfusion SPECT. Nucl Med Commun. 2015;36:494–501.PubMed
25.
Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, et al. Optimal left ventricular lead position predicts reverse remodelling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008;52:1402–9.CrossRefPubMed
26.
Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113:969–76.CrossRefPubMed
27.
Boogers MJ, Chen J, van Bommel RJ, Borleffs CJ, Dibbets-Schneider P, van der Hiel B, et al. Optimal left ventricular leads position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging. 2011;38:230–8.CrossRefPubMed
28.
•• Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF, et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J. 2011;32:93–103. Study demonstrating impact of scar in prediction of response to CRT in a large patient population.CrossRefPubMed
29.
Morishima I, Okumura K, Tsuboi H, Morita Y, Takagi K, Yoshida R, et al. Impact of basal inferolateral scar burden determined by automatic analysis of 99mTc-MIBI myocardial perfusion SPECT on the long-term prognosis of cardiac resynchronization therapy. Europace. 2016. Epub ahead of print.
30.
Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33–41.CrossRefPubMed
31.
Sommer A, Kronborg MB, Nørgaard BL, Poulsen SH, Bouchelouche K, Böttcher M, et al. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial. Eur J Heart Fail. 2016;18:1365–74.CrossRefPubMed
32.
Chen J, Garcia EV, Bax JJ, Iskandrian AE, Borges-Neto S, Soman P. SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony. J Nucl Cardiol. 2011;18:685–94.CrossRefPubMedPubMedCentral
33.
Muramatsu T, Matsumoto K, Nishimura S. Efficacy of the phase images in Fourier analysis using gated cardiac POOL-SPECT for determining the indication for cardiac resynchronization therapy. Circ J. 2005;69:1521–6.CrossRefPubMed
34.
Lalonde M, Birnie D, Ruddy TD, de Kemp RA, Beanlands RS, Wassenaar R, et al. SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response. Int J Cardiovasc Imaging. 2014;30:559–69.CrossRefPubMed
35.
Lalonde M, Wells RG, Birnie D, Ruddy TD, Wassenaar R. Development and optimization of SPECT gated blood pool cluster analysis for the prediction of CRT outcome. Med Phys. 2014;41:072506.CrossRefPubMed
36.
Cooke CD, Esteves FP, Chen J, Garcia EV. Left ventricular mechanical synchrony from stress and rest 82Rb PET myocardial perfusion ECG-gated studies: differentiating normal from LBBB patients. J Nucl Cardiol. 2011;18:1076–85.CrossRefPubMedPubMedCentral
37.
Pazhenkottil AP, Buechel RR, Nkoulou R, Ghadri JR, Herzog BA, Husmann L, et al. Left ventricular dyssynchrony assessment by phase analysis from gated PET-FDG scans. J Nucl Cardiol. 2011;18:920–5.CrossRefPubMed
38.
Lehner S, Uebleis C, Schüßler F, Haug A, Kääb S, Bartenstein P, et al. The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET. Eur J Nucl Med Mol Imaging. 2013;40:1876–83.CrossRefPubMed
39.
Uebleis C, Ulbrich M, Tegtmeyer R, Schuessler F, Haserueck N, Siebermair J, et al. Electrocardiogram-gated 18F-FDG PET/CT hybrid imaging in patients with unsatisfactory response to cardiac resynchronization therapy: initial clinical results. J Nucl Med. 2011;52:67–71.CrossRefPubMed
40.
Carrió I. Cardiac neurotransmission imaging. J Nucl Med. 2001;42:1062–76.PubMed
41.
Erol-Yilmaz A, Verberne HJ, Schrama TA, Hrudova J, DeWinter RJ, Van Eck-Smit BL, et al. Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin Electrophysiol. 2005;28:304–10.CrossRefPubMed
42.
Tanaka H, Tatsumi K, Fujiwara S, Tsuji T, Kaneko A, Ryo K, et al. Effect of left ventricular dyssynchrony on cardiac sympathetic activity in heart failure patients with wide QRS duration. Circ J. 2012;76:382–9.CrossRefPubMed
43.
Lishmanov Y, Minin S, Efimova I, Chernov V, Saushkina Y, Lebedev D, et al. The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure. Ann Nucl Med. 2013;27:378–85.CrossRefPubMed
44.
Zavadovsky KV, Gulya MO, Lishmanov YB, Lebedev DI. Perfusion and metabolic scintigraphy with (123) I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy. Ann Nucl Med. 2016;30:325–33.CrossRefPubMed
45.
Verna E, Ghiringhelli S, Scotti S, Caravati F. Evaluation of baseline contractile reserve vs dyssynchrony as a predictor of functional improvement and long term outcome after resynchronization pacing therapy: a radionuclide stress study. J Nucl Cardiol. 2012;19:53–62.CrossRefPubMed
46.
Chen Y, Yan J, Zhao S, Long Q, Wang H, Wang L. Efficacy of equilibrium radionuclide angiography to predict acute response to cardiac resynchronization therapy in patients with heart failure. Nucl Med Commun. 2015;36:610–8.CrossRefPubMed
47.
Tournoux F, Chequer R, Sroussi M, Hyafil F, Algalarrondo V, Cohen-Solal A, et al. Value of mechanical dyssynchrony as assessed by radionuclide ventriculography to predict the cardiac resynchronization therapy response. Eur Heart J Cardiovasc Imaging. 2016;17:1250–8.CrossRefPubMed
48.
Badhwar N, James J, Hoffmayer KS, O’Connell JW, Green DL, De Marco T, et al. Utility of equilibrium radionuclide angiogram derived measures of dyssynchrony to predict outcomes in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med. 2016;57:1880–6.CrossRefPubMed
49.
Nakamura K, Takami M, Shimabukuro M, Maesato A, Chinen I, Ishigaki S, et al. Effective prediction of response to cardiac resynchronization therapy using a novel program of gated myocardial perfusion single photon emission computed tomography. Europace. 2011;13:1731–7.CrossRefPubMed
50.
Kiso K, Imoto A, Nishimura Y, Kanzaki H, Noda T, Kamakura S, et al. Novel algorithm for quantitative assessment of left ventricular dyssynchrony with ECG-gated myocardial perfusion SPECT: useful technique for management of cardiac resynchronization therapy. Ann Nucl Med. 2011;25:768–76.CrossRefPubMed
51.
Azizian N, Rastgou F, Ghaedian T, Golabchi A, Bahadorian B, Khanlarzadeh V, et al. LV dyssynchrony assessed with phase analysis on gated myocardial perfusion SPECT can predict response to CRT in patients with end-stage heart failure. Res Cardiovasc Med. 2014;25:e20720.
52.
Qin S, Shi H, Su Y, Chen S, Pan W, Ge J. Can the prognosis of cardiac resynchronization therapy be predicted by gated SPECT? Clin Nucl Med. 2015;40:786–92.CrossRefPubMed
Metadata
Title
Nuclear Cardiology for the Prediction of Response to Cardiac Resynchronization Therapy
Authors
Chetan D. Patel
Anirban Mukherjee
Publication date
01-02-2017
Publisher
Springer US
Published in
Current Cardiovascular Imaging Reports / Issue 2/2017
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-017-9402-8

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits